Literature DB >> 17125423

The incidence of repeat uterine surgery following myomectomy.

Susan D Reed1, Katherine M Newton, Laura B Thompson, Brenna A McCrummen, Audrey K Warolin.   

Abstract

OBJECTIVE: To determine the incidence of subsequent leiomyoma surgery following myomectomy in a population-based cohort.
METHODS: All women, ages 20-75 years, enrolled in a large HMO in Washington State, identified by CPT and ICD-9 codes as having a myomectomy between January 1, 1993, and December 31, 2002, were eligible for the study. The follow-up period was 0.1-11 years. Automated enrollment and inpatient, outpatient, pathology, and procedure data were linked. Age-adjusted hazard ratios (HR) and 95% confidence intervals (CI) using Cox proportional hazard models, age-specific Kaplan Meier estimates of cumulative risk, and incidence of uterine surgery after myomectomy were calculated.
RESULTS: Among 628 eligible women, 127 (21.8%) had a second surgery, 95 (74.8%) of which were hysterectomies. The cumulative incidence of a second surgery was 23.5% at 5 years and 30% at 7 years. During 2766.5 woman-years of follow-up, the annual incidence of a subsequent myoma surgery was 4.6%. Compared with women aged 40-44, women >or=50 had a 50% decreased risk for subsequent surgery (HR = 0.5, 95% CI 0.3-0.9).
CONCLUSIONS: The incidence of subsequent surgery for leiomyomas following myomectomy is high, almost 5% per year.

Entities:  

Mesh:

Year:  2006        PMID: 17125423     DOI: 10.1089/jwh.2006.15.1046

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  11 in total

1.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

2.  Uterine fibroid embolization efficacy and safety: 15 years experience in an elevated turnout rate center.

Authors:  Carmine Di Stasi; Alessandro Cina; Francesco Rosella; Andrea Paladini; Sonia Amoroso; Daniela Romualdi; Riccardo Manfredi; Cesare Colosimo
Journal:  Radiol Med       Date:  2018-01-22       Impact factor: 3.469

3.  Effect of pregnancy on recurrence of symptomatic uterine myomas in women who underwent myomectomy.

Authors:  R T Aksoy; A Tokmak; A I Guzel; G Yildirim; M K Kokanali; M Doganay
Journal:  Hippokratia       Date:  2018 Jul-Sep       Impact factor: 0.471

4.  Route of myomectomy and fertility: a prospective cohort study.

Authors:  Lauren A Wise; Laine Thomas; Sophia Anderson; Donna D Baird; Raymond M Anchan; Kathryn L Terry; Erica E Marsh; Ganesa Wegienka; Wanda Kay Nicholson; Kedra Wallace; Robert Bigelow; James Spies; George L Maxwell; Vanessa Jacoby; Evan R Myers; Elizabeth A Stewart
Journal:  Fertil Steril       Date:  2022-02-23       Impact factor: 7.490

5.  Cost-effectiveness of uterine-preserving procedures for the treatment of uterine fibroid symptoms in the USA.

Authors:  Anne H Cain-Nielsen; James P Moriarty; Elizabeth A Stewart; Bijan J Borah
Journal:  J Comp Eff Res       Date:  2014-05-30       Impact factor: 1.744

Review 6.  The influence of uterine artery embolisation on ovarian reserve, fertility, and pregnancy outcomes - a review of literature.

Authors:  Piotr Czuczwar; Anna Stępniak; Wojciech Wrona; Sławomir Woźniak; Paweł Milart; Tomasz Paszkowski
Journal:  Prz Menopauzalny       Date:  2017-02-08

7.  Long-Term Clinical Outcomes of Transcervical Radiofrequency Ablation of Uterine Fibroids: The VITALITY Study.

Authors:  Jose Gerardo Garza-Leal
Journal:  J Gynecol Surg       Date:  2019-01-29

8.  Reoperation rates for recurrence of fibroids after abdominal myomectomy in women with large uterus.

Authors:  Katherine J Kramer; Sarah Ottum; Damla Gonullu; Capricia Bell; Hanna Ozbeki; Jay M Berman; Maurice-Andre Recanati
Journal:  PLoS One       Date:  2021-12-09       Impact factor: 3.240

9.  Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids.

Authors:  Amy K O'Sullivan; David Thompson; Paula Chu; David W Lee; Elizabeth A Stewart; Milton C Weinstein
Journal:  Int J Technol Assess Health Care       Date:  2009-01       Impact factor: 2.188

10.  Reintervention Rates After Myomectomy, Endometrial Ablation, and Uterine Artery Embolization for Patients with Uterine Fibroids.

Authors:  Matthew R Davis; Ahmed M Soliman; Jane Castelli-Haley; Michael C Snabes; Eric S Surrey
Journal:  J Womens Health (Larchmt)       Date:  2018-08-07       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.